{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T18:22:22Z","timestamp":1789842142203,"version":"4.0.1"},"reference-count":90,"publisher":"Deutscher Arzte-Verlag GmbH","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.3238\/arztebl.2018.0365","type":"journal-article","created":{"date-parts":[[2018,5,25]],"date-time":"2018-05-25T05:42:10Z","timestamp":1527226930000},"source":"Crossref","is-referenced-by-count":21,"title":["Chronic Headache Due to Overuse of Analgesics and Anti-Migraine Agents"],"prefix":"10.3238","author":[{"given":"Hans-Christoph","family":"Diener","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dagny","family":"Holle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Dresler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charly","family":"Gaul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"11437","published-online":{"date-parts":[[2018,6,1]]},"reference":[{"key":"10.3238\/arztebl.2018.0365_ref1","doi-asserted-by":"crossref","unstructured":"Headache Classification Committee of the International Headache Society (IHS). The International Classification of Headache Disorders ICHD-3, 3rd edition. Cephalalgia 2018; 38: 1\u2013211.","DOI":"10.1177\/0333102417738202"},{"key":"10.3238\/arztebl.2018.0365_ref2","doi-asserted-by":"crossref","unstructured":"Dichgans J, Diener HC, Gerber WD, Verspohl EJ, Kukiolka H, Kluck M: Analgetika-induzierter Dauerkopfschmerz. Dtsch med Wschr 1984; 109: 369\u201373","DOI":"10.1055\/s-2008-1069197"},{"key":"10.3238\/arztebl.2018.0365_ref3","doi-asserted-by":"crossref","unstructured":"Bahra A, Walsh M, Menon S, Goadsby PJ: Does chronic daily headache arise de novo in association with regular use of analgesics? Headache 2003; 43: 179\u201390","DOI":"10.1046\/j.1526-4610.2003.03041.x"},{"key":"10.3238\/arztebl.2018.0365_ref4","doi-asserted-by":"crossref","unstructured":"Paemeleire K, Evers S, Goadsby PJ: Medication-overuse headache in patients with cluster headache. Curr Pain Headache Rep 2008; 12: 122\u20137","DOI":"10.1007\/s11916-008-0023-4"},{"key":"10.3238\/arztebl.2018.0365_ref5","doi-asserted-by":"crossref","unstructured":"Straube A, Pfaffenrath V, Ladwig KH, et al.: Prevalence of chronic migraine and medication overuse headache in Germany\u2014the German DMKG headache study. Cephalalgia 2010; 30: 207\u201313","DOI":"10.1111\/j.1468-2982.2009.01906.x"},{"key":"10.3238\/arztebl.2018.0365_ref6","doi-asserted-by":"crossref","unstructured":"Schramm SH, Obermann M, Katsarava Z, Diener HC, Moebus S, Yoon MS: Epidemiological profiles of patients with chronic migraine and chronic tension-type headache. J Headache Pain 2013; 14: 40","DOI":"10.1186\/1129-2377-14-40"},{"key":"10.3238\/arztebl.2018.0365_ref7","doi-asserted-by":"crossref","unstructured":"Stovner L, Hagen K, Jensen R, et al.: The global burden of headache: a documentation of headache prevalence and disability worldwide. Cephalalgia 2007; 27: 193\u2013210","DOI":"10.1111\/j.1468-2982.2007.01288.x"},{"key":"10.3238\/arztebl.2018.0365_ref8","doi-asserted-by":"crossref","unstructured":"Jonsson P, Hedenrud T, Linde M: Epidemiology of medication overuse headache in the general Swedish population. Cephalalgia 2011; 31: 1015\u201322","DOI":"10.1177\/0333102411410082"},{"key":"10.3238\/arztebl.2018.0365_ref9","doi-asserted-by":"crossref","unstructured":"Diener HC, Limmroth V: Medication-overuse headache: a worldwide problem. Lancet Neurology 2004; 3: 475\u201383","DOI":"10.1016\/S1474-4422(04)00824-5"},{"key":"10.3238\/arztebl.2018.0365_ref10","doi-asserted-by":"crossref","unstructured":"Dyb G, Holmen TL, Zwart JA: Analgesic overuse among adolescents with headache: the Head-HUNT-Youth Study. Neurology 2006; 66: 198\u2013201","DOI":"10.1212\/01.wnl.0000193630.03650.19"},{"key":"10.3238\/arztebl.2018.0365_ref11","doi-asserted-by":"crossref","unstructured":"Lipton RB, Manack A, Ricci JA, Chee E, Turkel CC, Winner P: Prevalence and burden of chronic migraine in adolescents: results of the chronic daily headache in adolescents study (C-dAS). Headache 2011; 51: 693\u2013706","DOI":"10.1111\/j.1526-4610.2011.01885.x"},{"key":"10.3238\/arztebl.2018.0365_ref12","doi-asserted-by":"crossref","unstructured":"Limmroth V, Katsarava Z, Fritsche G, Przywara S, Diener H: Features of medication overuse headache following overuse of different acute headache drugs. Neurology 2002; 59: 1011\u20134","DOI":"10.1212\/WNL.59.7.1011"},{"key":"10.3238\/arztebl.2018.0365_ref13","doi-asserted-by":"crossref","unstructured":"Galvin JA, van Stavern GP: Clinical characterization of idiopathic intracranial hypertension at the Detroit Medical Center. J Neurol Sci 2004; 223: 157\u201360","DOI":"10.1016\/j.jns.2004.05.009"},{"key":"10.3238\/arztebl.2018.0365_ref14","doi-asserted-by":"crossref","unstructured":"Radat F, Creac\u2018h C, Guegan-Massardier E, et al.: Behavioral dependence in patients with medication overuse headache: a cross-sectional study in consulting patients using the DSM-IV criteria. Headache 2008; 48: 1026\u201336","DOI":"10.1111\/j.1526-4610.2007.00999.x"},{"key":"10.3238\/arztebl.2018.0365_ref15","doi-asserted-by":"crossref","unstructured":"de Goffau MJ, Klaver AR, Willemsen MG, Bindels PJ, Verhagen AP: The effectiveness of treatments for patients with medication overuse headache: a systematic review and meta-analysis. J Pain 2017; 18: 615\u2013627","DOI":"10.1016\/j.jpain.2016.12.005"},{"key":"10.3238\/arztebl.2018.0365_ref16","doi-asserted-by":"crossref","unstructured":"Krause SJ, Stillman MJ, Tepper DE, Zajac D: A prospective cohort study of outpatient interdisciplinary rehabilitation of chronic headache patients. Headache 2017; 57: 428\u201340","DOI":"10.1111\/head.13020"},{"key":"10.3238\/arztebl.2018.0365_ref17","doi-asserted-by":"crossref","unstructured":"Diener HC, Bussone G, van Oene JC, Lahaye M, Schwalen S, Goadsby PJ: Topiramate reduces headache days in chronic migraine: a randomized, double-blind, placebo-controlled study. Cephalalgia 2007; 27: 814\u201323","DOI":"10.1111\/j.1468-2982.2007.01326.x"},{"key":"10.3238\/arztebl.2018.0365_ref18","doi-asserted-by":"crossref","unstructured":"Silberstein S, Lipton R, Dodick D, et al.: Topiramate treatment of chronic migraine: a randomized, placebo-controlled trial of quality of life and other efficacy measures. Headache 2009; 49: 1153\u201362","DOI":"10.1111\/j.1526-4610.2009.01508.x"},{"key":"10.3238\/arztebl.2018.0365_ref19","doi-asserted-by":"crossref","unstructured":"Diener HC, Dodick DW, Goadsby PJ, et al.: Utility of topiramate for the treatment of patients with chronic migraine in the presence or absence of acute medication overuse. Cephalalgia 2009; 29: 1021\u20137","DOI":"10.1111\/j.1468-2982.2009.01859.x"},{"key":"10.3238\/arztebl.2018.0365_ref20","doi-asserted-by":"crossref","unstructured":"Romigi A, Cervellino A, Marciani MG, et al.: Cognitive and psychiatric effects of topiramate monotherapy in migraine treatment: an open study. Eur J Neurol 2008; 15: 190\u20135","DOI":"10.1111\/j.1468-1331.2007.02033.x"},{"key":"10.3238\/arztebl.2018.0365_ref21","doi-asserted-by":"crossref","unstructured":"Dodick DW, Turkel CC, DeGryse RE, et al.: Onabotulinumtoxin A for treatment of chronic migraine: pooled results from the double-blind, randomized, placebo-controlled phases of the PREEMPT clinical program. Headache 2010; 50: 921\u201336","DOI":"10.1111\/j.1526-4610.2010.01678.x"},{"key":"10.3238\/arztebl.2018.0365_ref22","doi-asserted-by":"crossref","unstructured":"Silberstein SD, Blumenfeld AM, Cady RK, et al.: Onabotulinumtoxin A for treatment of chronic migraine: PREEMPT 24-week pooled subgroup analysis of patients who had acute headache medication overuse at baseline. J Neurol Sci 2013; 331: 48\u201356","DOI":"10.1016\/j.jns.2013.05.003"},{"key":"10.3238\/arztebl.2018.0365_ref23","doi-asserted-by":"crossref","unstructured":"Chiang CC, Schwedt TJ, Wang SJ, Dodick DW: Treatment of medication-overuse headache: a systematic review. Cephalalgia 2015","DOI":"10.1177\/0333102415593088"},{"key":"10.3238\/arztebl.2018.0365_ref24","doi-asserted-by":"crossref","unstructured":"Rabe K, Pageler L, Gaul C, et al.: Prednisone for the treatment of withdrawal headache in patients with medication overuse headache: a randomized, double-blind, placebo-controlled study. Cephalalgia 2013; 33: 202\u20137","DOI":"10.1177\/0333102412462638"},{"key":"10.3238\/arztebl.2018.0365_ref25","doi-asserted-by":"crossref","unstructured":"Boe MG, Mygland A, Salvesen R: Prednisolone does not reduce withdrawal headache: a randomized, double-blind study. Neurology 2007; 69: 26\u201331","DOI":"10.1212\/01.wnl.0000263652.46222.e8"},{"key":"10.3238\/arztebl.2018.0365_ref26","doi-asserted-by":"crossref","unstructured":"Katsarava Z, Fritsche G, Muessig M, Diener HC, Limmroth V: Clinical features of withdrawal headache following overuse of triptans and other headache drugs. Neurology 2001; 57: 1694\u20138","DOI":"10.1212\/WNL.57.9.1694"},{"key":"10.3238\/arztebl.2018.0365_ref27","doi-asserted-by":"crossref","unstructured":"Gowing L, Farrell M, Ali R, White JM: Alpha(2)-adrenergic agonists for the management of opioid withdrawal. Cochrane Database Syst Rev 2016: CD002024","DOI":"10.1002\/14651858.CD002024.pub5"},{"key":"10.3238\/arztebl.2018.0365_ref28","doi-asserted-by":"crossref","unstructured":"Tassorelli C, Jensen R, Allena M, et al.: A consensus protocol for the management of medication-overuse headache: evaluation in a multicentric, multinational study. Cephalalgia 2014; 34: 645\u201355","DOI":"10.1177\/0333102414521508"},{"key":"10.3238\/arztebl.2018.0365_ref29","doi-asserted-by":"crossref","unstructured":"Gaul C, van Doorn C, Webering N, et al.: Clinical outcome of a headache-specific multidisciplinary treatment program and adherence to treatment recommendations in a tertiary headache center: an observational study. J Headache Pain 2011; 12: 475\u201383","DOI":"10.1007\/s10194-011-0348-y"},{"key":"10.3238\/arztebl.2018.0365_ref30","doi-asserted-by":"crossref","unstructured":"Westergaard ML, Hansen EH, Glumer C, Jensen RH: Prescription pain medications and chronic headache in Denmark: implications for preventing medication overuse. Eur J Clin Pharmacol 2015; 71: 851\u201360","DOI":"10.1007\/s00228-015-1858-3"},{"key":"10.3238\/arztebl.2018.0365_ref31","doi-asserted-by":"crossref","unstructured":"Fritsche G, Frettloh J, Huppe M, et al.: Prevention of medication overuse in patients with migraine. Pain 2010; 151: 404\u201313","DOI":"10.1016\/j.pain.2010.07.032"},{"key":"10.3238\/arztebl.2018.0365_ref32","doi-asserted-by":"crossref","unstructured":"Scher AI, Rizzoli PB, Loder EW: Medication overuse headache: an entrenched idea in need of scrutiny. Neurology 2017; 89: 1296\u2013304","DOI":"10.1212\/WNL.0000000000004371"},{"key":"10.3238\/arztebl.2018.0365_ref33","doi-asserted-by":"crossref","unstructured":"Hagen K, Linde M, Steiner TJ, Stovner LJ, Zwart JA: Risk factors for medication-overuse headache: an 11-year follow-up study. The Nord-Tr\u00f8ndelag Health Studies. Pain 2012; 153: 56\u201361","DOI":"10.1016\/j.pain.2011.08.018"},{"key":"10.3238\/arztebl.2018.0365_ref34","doi-asserted-by":"crossref","unstructured":"Scher AI, Lipton RB, Stewart WF, Bigal M: Patterns of medication use by chronic and episodic headache sufferers in the general population: results from the frequent headache epidemiology study. Cephalalgia 2010; 30: 321\u20138","DOI":"10.1111\/j.1468-2982.2009.01913.x"},{"key":"10.3238\/arztebl.2018.0365_ref35","doi-asserted-by":"crossref","unstructured":"He Z, Dong L, Zhang Y, Kong Q, Tan G, Zhou J: Metabolic syndrome in female migraine patients is associated with medication overuse headache: a clinic-based study in China. Euro J Neurol 2015; 22: 1228\u201334","DOI":"10.1111\/ene.12732"},{"key":"10.3238\/arztebl.2018.0365_ref36","doi-asserted-by":"crossref","unstructured":"Diener HC, Holle D, Solbach K, Gaul C: Medication-overuse headache: risk factors, pathophysiology and management. Nat Rev Neurol 2016; 12: 575\u201383.","DOI":"10.1038\/nrneurol.2016.124"},{"key":"10.3238\/arztebl.2018.0365_ref37","doi-asserted-by":"crossref","unstructured":"Westergaard ML, Glumer C, Hansen EH, Jensen RH: Prevalence of chronic headache with and without medication overuse: associations with socioeconomic position and physical and mental health status. Pain 2014; 155: 2005\u201313","DOI":"10.1016\/j.pain.2014.07.002"},{"key":"10.3238\/arztebl.2018.0365_ref38","doi-asserted-by":"crossref","unstructured":"Castillo J, Munoz P, Guitera V, Pascual J: Epidemiology of chronic daily headache in the general population. Headache 1999; 39: 190\u20136","DOI":"10.1046\/j.1526-4610.1999.3903190.x"},{"key":"10.3238\/arztebl.2018.0365_ref39","doi-asserted-by":"crossref","unstructured":"Wang SJ, Fuh JL, Lu SR, et al.: Chronic daily headache in chinese elderly\u2014prevalence, risk factors, and biannual follow-up. Neurology 2000; 54: 314\u20139","DOI":"10.1212\/WNL.54.2.314"},{"key":"10.3238\/arztebl.2018.0365_ref40","doi-asserted-by":"crossref","unstructured":"Lu SR, Fuh JL, Chen WT, Juang KD, Wang SJ: Chronic daily headache in Taipei, Taiwan: prevalence, follow-up and outcome predictors. Cephalalgia 2001; 21: 980\u20136","DOI":"10.1046\/j.1468-2982.2001.00294.x"},{"key":"10.3238\/arztebl.2018.0365_ref41","doi-asserted-by":"crossref","unstructured":"Pascual J, Colas R, Castillo J: Epidemiology of chronic daily headache. Curr Pain Headache Rep 2001; 5: 529\u201336","DOI":"10.1007\/s11916-001-0070-6"},{"key":"10.3238\/arztebl.2018.0365_ref42","doi-asserted-by":"crossref","unstructured":"Prencipe M, Casini AR, Ferretti C, et al.: Prevalence of headache in an elderly population: attack frequency, disability, and use of medication. J Neurol Neurosurg Psychiatry 2001; 70: 377\u201381","DOI":"10.1136\/jnnp.70.3.377"},{"key":"10.3238\/arztebl.2018.0365_ref43","doi-asserted-by":"crossref","unstructured":"Colas R, Munoz P, Temprano R, Gomez C, Pascual J: Chronic daily headache with analgesic overuse: epidemiology and impact on quality of life. Neurology 2004; 62: 1338\u201342","DOI":"10.1212\/01.WNL.0000120545.45443.93"},{"key":"10.3238\/arztebl.2018.0365_ref44","doi-asserted-by":"crossref","unstructured":"Zwart J, Dyb G, Hagen K, Svebak S, Stovner L, Holmen J: Analgesic overuse among subjects with headache, neck, and low back pain. Neurology 2004; 62: 1540\u20134","DOI":"10.1212\/01.WNL.0000123262.96132.FC"},{"key":"10.3238\/arztebl.2018.0365_ref45","doi-asserted-by":"crossref","unstructured":"Dyb G, Holmen TL, Zwart JA: Analgesic overuse among adolescents with headache: the Head-HUNT-Youth Study. Neurology 2006; 66: 198\u2013201","DOI":"10.1212\/01.wnl.0000193630.03650.19"},{"key":"10.3238\/arztebl.2018.0365_ref46","doi-asserted-by":"crossref","unstructured":"Wang SJ, Fuh JL, Lu SR, Juang KD: Chronic daily headache in adolescents: prevalence, impact, and medication overuse. Neurology 2006; 66: 193\u20137","DOI":"10.1212\/01.wnl.0000183555.54305.fd"},{"key":"10.3238\/arztebl.2018.0365_ref47","doi-asserted-by":"crossref","unstructured":"Wiendels NJ, Knuistingh NA, Rosendaal FR, et al.: Chronic frequent headache in the general population: prevalence and associated factors. Cephalalgia 2006; 26: 1434\u201342","DOI":"10.1111\/j.1468-2982.2006.01210.x"},{"key":"10.3238\/arztebl.2018.0365_ref48","doi-asserted-by":"crossref","unstructured":"Aaseth K, Grande RB, Kvaerner KJ, Gulbrandsen P, Lundqvist C, Russell MB: Prevalence of secondary chronic headaches in a population-based sample of 30\u201344-year-old persons. The Akershus study of chronic headache. Cephalalgia 2008; 28: 705\u201313","DOI":"10.1111\/j.1468-2982.2008.01577.x"},{"key":"10.3238\/arztebl.2018.0365_ref49","doi-asserted-by":"crossref","unstructured":"Aaseth K, Grande RB, Lundqvist C, Russell MB: What is chronic headache in the general population? The Akershus study of chronic headache. Acta Neurol Scand Suppl 2009: 30\u20132","DOI":"10.1111\/j.1600-0404.2009.01209.x"},{"key":"10.3238\/arztebl.2018.0365_ref50","doi-asserted-by":"crossref","unstructured":"Rueda-Sanchez M, Diaz-Martinez LA: Prevalence and associated factors for episodic and chronic daily headache in the Colombian population. Cephalalgia 2008; 28: 216\u201325","DOI":"10.1111\/j.1468-2982.2007.01499.x"},{"key":"10.3238\/arztebl.2018.0365_ref51","doi-asserted-by":"crossref","unstructured":"Katsarava Z, Dzagnidze A, Kukava M, et al.: Primary headache disorders in the Republic of Georgia: prevalence and risk factors. Neurology 2009; 73: 1796\u2013803","DOI":"10.1212\/WNL.0b013e3181c34abb"},{"key":"10.3238\/arztebl.2018.0365_ref52","doi-asserted-by":"crossref","unstructured":"da Silva Jr A, Costa EC, Gomes JB, et al.: Chronic headache and comorbibities: a two-phase, population-based, cross-sectional study. Headache 2010, 50. 1306\u201312.","DOI":"10.1111\/j.1526-4610.2010.01620.x"},{"key":"10.3238\/arztebl.2018.0365_ref53","doi-asserted-by":"crossref","unstructured":"Straube A, Pfaffenrath V, Ladwig KH, et al.: Prevalence of chronic migraine and medication overuse headache in Germany\u2014the German DMKG headache study. Cephalalgia 2010; 30: 207\u201313","DOI":"10.1111\/j.1468-2982.2009.01906.x"},{"key":"10.3238\/arztebl.2018.0365_ref54","doi-asserted-by":"crossref","unstructured":"Jonsson P, Hedenrud T, Linde M: Epidemiology of medication overuse headache in the general Swedish population. Cephalalgia 2011; 31: 1015\u201322","DOI":"10.1177\/0333102411410082"},{"key":"10.3238\/arztebl.2018.0365_ref55","doi-asserted-by":"crossref","unstructured":"Jonsson P, Linde M, Hensing G, Hedenrud T: Sociodemographic differences in medication use, health-care contacts and sickness absence among individuals with medication-overuse headache. J Headache Pain 2012; 13: 281\u201390","DOI":"10.1007\/s10194-012-0432-y"},{"key":"10.3238\/arztebl.2018.0365_ref56","doi-asserted-by":"crossref","unstructured":"Linde M, Stovner LJ, Zwart JA, Hagen K: Time trends in the prevalence of headache disorders. The Nord-Tr\u00f8ndelag Health Studies (HUNT 2 and HUNT 3). Cephalalgia 2011; 31: 585\u201396","DOI":"10.1177\/0333102410391488"},{"key":"10.3238\/arztebl.2018.0365_ref57","doi-asserted-by":"crossref","unstructured":"Lipton RB, Manack A, Ricci JA, Chee E, Turkel CC, Winner P: Prevalence and burden of chronic migraine in adolescents: results of the chronic daily headache in adolescents study (C-dAS). Headache 2011; 51: 693\u2013706","DOI":"10.1111\/j.1526-4610.2011.01885.x"},{"key":"10.3238\/arztebl.2018.0365_ref58","doi-asserted-by":"crossref","unstructured":"Ayzenberg I, Katsarava Z, Sborowski A, et al.: The prevalence of primary headache disorders in Russia: a countrywide survey. Cephalalgia 2012; 32: 373\u201381","DOI":"10.1177\/0333102412438977"},{"key":"10.3238\/arztebl.2018.0365_ref59","doi-asserted-by":"crossref","unstructured":"Ertas M, Baykan B, Orhan EK, et al.: One-year prevalence and the impact of migraine and tension-type headache in Turkey: a nationwide home-based study in adults. J Headache Pain 2012; 13: 147\u201357","DOI":"10.1007\/s10194-011-0414-5"},{"key":"10.3238\/arztebl.2018.0365_ref60","doi-asserted-by":"crossref","unstructured":"Hagen K, Linde M, Steiner TJ, Stovner LJ, Zwart JA: Risk factors for medication-overuse headache: an 11-year follow-up study. The Nord-Tr\u00f8ndelag Health Studies. Pain 2012; 153: 56\u201361","DOI":"10.1016\/j.pain.2011.08.018"},{"key":"10.3238\/arztebl.2018.0365_ref61","doi-asserted-by":"crossref","unstructured":"Shahbeigi S, Fereshtehnejad SM, Mohammadi N, et al.: Epidemiology of headaches in Tehran urban area: a population-based cross-sectional study in district 8, year 2010. Neurol Sci\u00a02013; 34: 1157\u201366","DOI":"10.1007\/s10072-012-1200-0"},{"key":"10.3238\/arztebl.2018.0365_ref62","doi-asserted-by":"crossref","unstructured":"Yu S, Liu R, Zhao G, et al.: The prevalence and burden of primary headaches in China: a population-based door-to-door survey. Headache 2012; 52: 582\u201391","DOI":"10.1111\/j.1526-4610.2011.02061.x"},{"key":"10.3238\/arztebl.2018.0365_ref63","doi-asserted-by":"crossref","unstructured":"Schramm SH, Obermann M, Katsarava Z, Diener HC, Moebus S, Yoon MS: Epidemiological profiles of patients with chronic migraine and chronic tension-type headache. J Headache Pain 2013; 14: 40","DOI":"10.1186\/1129-2377-14-40"},{"key":"10.3238\/arztebl.2018.0365_ref64","doi-asserted-by":"crossref","unstructured":"Park JW, Moon HS, Kim JM, Lee KS, Chu MK: Chronic daily headache in Korea: prevalence, clinical characteristics, medical consultation and management. J Clin Neurol 2014; 10: 236\u201343 MEDLINE","DOI":"10.3988\/jcn.2014.10.3.236"},{"key":"10.3238\/arztebl.2018.0365_ref65","doi-asserted-by":"crossref","unstructured":"Westergaard ML, Glumer C, Hansen EH, Jensen RH: Medication overuse, healthy lifestyle behaviour and stress in chronic headache: results from a population-based representative survey. Cephalalgia 2016; 36: 15\u201328","DOI":"10.1177\/0333102415578430"},{"key":"10.3238\/arztebl.2018.0365_ref66","doi-asserted-by":"crossref","unstructured":"Kristoffersen ES, Lundqvist C: Medication-overuse headache: epidemiology, diagnosis and treatment. Ther Adv Drug Saf 2014; 5: 87\u201399","DOI":"10.1177\/2042098614522683"},{"key":"10.3238\/arztebl.2018.0365_ref67","doi-asserted-by":"crossref","unstructured":"Steiner TJ, Stovner LJ, Katsarava Z, et al.: The impact of headache in Europe: principal results of the Eurolight project. J Headache Pain 2014; 15: 31 MEDLINE","DOI":"10.1186\/1129-2377-15-31"},{"key":"10.3238\/arztebl.2018.0365_ref68","doi-asserted-by":"crossref","unstructured":"Westergaard ML, Hansen EH, Glumer C, Jensen RH: Prescription pain medications and chronic headache in Denmark: implications for preventing medication overuse. Eur J Clin Pharmacol 2015; 71: 851\u201360","DOI":"10.1007\/s00228-015-1858-3"},{"key":"10.3238\/arztebl.2018.0365_ref69","doi-asserted-by":"crossref","unstructured":"Bravo TP: Headaches of the elderly. Curr Neurol Neurosci Rep 2015; 15: 30","DOI":"10.1007\/s11910-015-0552-2"},{"key":"10.3238\/arztebl.2018.0365_ref70","doi-asserted-by":"crossref","unstructured":"Mbewe E, Zairemthiama P, Yeh HH, Paul R, Birbeck GL, Steiner TJ: The epidemiology of primary headache disorders in Zambia: a population-based door-to-door survey. J Headache Pain 2015; 16: 515","DOI":"10.1186\/s10194-015-0515-7"},{"key":"10.3238\/arztebl.2018.0365_ref71","doi-asserted-by":"crossref","unstructured":"Kulkarni GB, Rao GN, Gururaj G, Stovner LJ, Steiner TJ: Headache disorders and public ill-health in India: prevalence estimates in Karnataka State. J Headache Pain 2015; 16: 67","DOI":"10.1186\/s10194-015-0549-x"},{"key":"10.3238\/arztebl.2018.0365_ref72","doi-asserted-by":"crossref","unstructured":"Manandhar K, Risal A, Linde M, Steiner TJ: The burden of headache disorders in Nepal: estimates from a population-based survey. J Headache Pain 2015; 17: 3","DOI":"10.1186\/s10194-016-0594-0"},{"key":"10.3238\/arztebl.2018.0365_ref73","doi-asserted-by":"crossref","unstructured":"Zebenigus M, Tekle-Haimanot R, Worku DK, Thomas H, Steiner TJ: The prevalence of primary headache disorders in Ethiopia. J Headache Pain 2016; 17: 110","DOI":"10.1186\/s10194-016-0704-z"},{"key":"10.3238\/arztebl.2018.0365_ref74","doi-asserted-by":"crossref","unstructured":"Al-Hashel JY, Ahmed SF, Alroughani R: Prevalence of primary headache disorders in Kuwait. Neuroepidemiology 2017; 48: 138\u201346","DOI":"10.1159\/000478892"},{"key":"10.3238\/arztebl.2018.0365_ref75","doi-asserted-by":"crossref","unstructured":"Rastenyte D, Mickeviciene D, Stovner LJ, Thomas H, Andree C, Steiner TJ: Prevalence and burden of headache disorders in Lithuania and their public-health and policy implications: a population-based study within the Eurolight project. J Headache Pain 2017; 18: 53","DOI":"10.1186\/s10194-017-0759-5"},{"key":"10.3238\/arztebl.2018.0365_ref76","doi-asserted-by":"crossref","unstructured":"Henning V, Katsarava Z, Obermann M, Moebus S, Schramm S: Remission of chronic headache: rates, potential predictors and the role of medication, follow-up results of the German Headache Consortium (GHC) Study. Cephalalgia 2017: 333102417699180.","DOI":"10.1177\/0333102417699180"},{"key":"10.3238\/arztebl.2018.0365_ref77","unstructured":"Global Burden of Disease Neurological Disorders Collaborator Group: Global, regional, and national burden of neurological disorders during 1990\u20132015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet Neurol 2017; 16: 877\u201397"},{"key":"10.3238\/arztebl.2018.0365_ref78","doi-asserted-by":"crossref","unstructured":"Lance F, Parkes C, Wilkinson M: Does analgesic abuse cause headaches de novo? Headache 1988; 28: 61\u20132","DOI":"10.1111\/j.1526-4610.1988.hed2801060_2.x"},{"key":"10.3238\/arztebl.2018.0365_ref79","doi-asserted-by":"crossref","unstructured":"Di Lorenzo C, Coppola G, Curra A, et al.: Cortical response to somatosensory stimulation in medication overuse headache patients is influenced by angiotensin converting enzyme (ACE) I\/D genetic polymorphism. Cephalalgia 2012; 32: 1189\u201397","DOI":"10.1177\/0333102412461890"},{"key":"10.3238\/arztebl.2018.0365_ref80","doi-asserted-by":"crossref","unstructured":"di Lorenzo C, di Lorenzo G, Sances G, et al.: Drug consumption in medication overuse headache is influenced by brain-derived neurotrophic factor Val66Met polymorphism. J Headache Pain 2009; 10: 349\u201355","DOI":"10.1007\/s10194-009-0136-0"},{"key":"10.3238\/arztebl.2018.0365_ref81","doi-asserted-by":"crossref","unstructured":"Cargnin S, Viana M, Ghiotto N, et al.: Functional polymorphisms in COMT and SLC6A4 genes influence the prognosis of patients with medication overuse headache after withdrawal therapy. Eur J Neurol 2014; 21: 989\u201395","DOI":"10.1111\/ene.12424"},{"key":"10.3238\/arztebl.2018.0365_ref82","doi-asserted-by":"crossref","unstructured":"Srikiatkhachorn A, Anthony M: Serotonin receptor adaptation in patients with analgesic-induced headache. Cephalalgia 1996; 16: 419\u201322","DOI":"10.1046\/j.1468-2982.1996.1606419.x"},{"key":"10.3238\/arztebl.2018.0365_ref83","doi-asserted-by":"crossref","unstructured":"Srikiatkhachorn A, Anthony M: Platelet serotonin in patients with analgesic-induced headache. Cephalalgia 1996; 16: 423\u20136","DOI":"10.1046\/j.1468-2982.1996.1606423.x"},{"key":"10.3238\/arztebl.2018.0365_ref84","doi-asserted-by":"crossref","unstructured":"Srikiatkhachorn A, Puangniyom S, Govitrapong P: Plasticity of 5-HT serotonin receptor in patients with analgesic-induced transformed migraine. Headache 1998; 38: 534","DOI":"10.1046\/j.1526-4610.1998.3807534.x"},{"key":"10.3238\/arztebl.2018.0365_ref85","doi-asserted-by":"crossref","unstructured":"Rossi C, Pini LA, Cupini ML, Calabresi P, Sarchielli P: Endocannabinoids in platelets of chronic migraine patients and medication-overuse headache patients: relation with serotonin levels. Eur J Clin Pharmacol 2008; 64: 1\u20138","DOI":"10.1007\/s00228-007-0391-4"},{"key":"10.3238\/arztebl.2018.0365_ref86","doi-asserted-by":"crossref","unstructured":"Cupini LM, Costa C, Sarchielli P, et al.: Degradation of endocannabinoids in chronic migraine and medication overuse headache. Neurobiol Dis 2008; 30: 186\u20139","DOI":"10.1016\/j.nbd.2008.01.003"},{"key":"10.3238\/arztebl.2018.0365_ref87","doi-asserted-by":"crossref","unstructured":"Ayzenberg I, Obermann M, Nyhuis P, et al.: Central sensitization of the trigeminal and somatic nociceptive systems in medication overuse headache mainly involves cerebral supraspinal structures. Cephalalgia 2006; 26: 1106\u201314","DOI":"10.1111\/j.1468-2982.2006.01183.x"},{"key":"10.3238\/arztebl.2018.0365_ref88","doi-asserted-by":"crossref","unstructured":"Ferraro D, Vollono C, Miliucci R, et al.: Habituation to pain in \u201emedication overuse headache\u201c: a CO2 laser-evoked potential study. Headache 2012; 52: 792\u2013807","DOI":"10.1111\/j.1526-4610.2012.02151.x"},{"key":"10.3238\/arztebl.2018.0365_ref89","doi-asserted-by":"crossref","unstructured":"Schwedt TJ, Chong CD: Medication overuse headache: pathophysiological insights from structural and functional brain MRI research. Headache 2017; 57: 1173\u20138","DOI":"10.1111\/head.13037"},{"key":"10.3238\/arztebl.2018.0365_ref90","unstructured":"IHS Classification ICHD-3. www.ichd-3.org\/8-headache-attributed-to-a-substance-or-its-withdrawal\/ (last accessed on 9 April 2018)."}],"container-title":["Deutsches \u00c4rzteblatt international"],"original-title":[],"link":[{"URL":"https:\/\/www.aerzteblatt.de\/10.3238\/arztebl.2018.0365","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,6]],"date-time":"2021-12-06T13:42:22Z","timestamp":1638798142000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.aerzteblatt.de\/10.3238\/arztebl.2018.0365"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6,1]]},"references-count":90,"URL":"https:\/\/doi.org\/10.3238\/arztebl.2018.0365","relation":{},"ISSN":["1866-0452"],"issn-type":[{"value":"1866-0452","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,6,1]]}}}